Partner with the World’s Leading Forum for Diagnostics Stakeholders
Backed by 16 years of scientific knowledge exchange and hyper-aligned networking, this forum is the industry’s most established biomarker and drug-diagnostic forum fueling the latest precision medicine strides across oncology, and neurological, autoimmune, chronic, and rare disease indications.
Serving as the global hub for the precision medicine community, the 16th World Clinical Biomarkers & Companion Diagnostics Summit united 850+ biopharma, testing labs, diagnostic development, regulation, and reimbursement leaders, offering a high-impact platform to connect, partner, and the chance to grow the industry visibility of your services.
If you have relevant services and would like to align your company within the precision medicine community, contact us to promote your brand through a bespoke commercial package. Email sponsor@hansonwade.com to request more information about the 2027 event.
What to Expect in 2027?
Meet New Clients
Expand your client base within the global precision medicine community by networking face-to-face with dedicated senior attendees actively seeking solutions to overcome their biomarker and drug-diagnostic challenges.
Centre Yourself in Biopharma Deal-Making
Position your brand in front of C-level decision-makers by showcasing your company logo on event materials including our website, brochure, and on site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and first-hand strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Advancing compliant companion diagnostics solutions from bench-to-bedside
Improving patient selection and monitoring with liquid biopsy platforms
Identifying clinically meaningful biomarkers with novel biomarker assay development and validation
Bolstering accessible and scalable diagnostic testing through clinical laboratories
Accelerating towards harmonized drug-diagnostic approvals with IVD compliance and regulatory adherence
Enhancing data-driven strategies with AI-enabled biomarker discovery and clinical decision support
A Quick Audience Breakdown
Take a sneak preview at the 850+ senior stakeholders who joined us for the 16th World Clinical Biomarkers & Companion Diagnostics Summit.
Company Types
Seniority
Expertise & Job Titles
*Statistics Taken from 15th World Clinical Biomarkers & Companion Diagnostics Summit
Attending Companies Included
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals